Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.
Alzheimer's 'First' Achieved With Drug That Hits Hotspots
Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in ...
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
verywellhealth13d
CADASIL: Dementia Onset, Statistics, Clinical Trials
CADASIL is a brain disease involving genetic mutations, stroke, and dementia. Learn about symptom progression and ongoing ...
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...
studyfinds1d
Brain scans reveal unique ‘fingerprints’ in every case of Alzheimer’s disease
Researchers suggest that the way Alzheimer's reshapes our brains is as unique as our fingerprints, challenging long-held ...
Cannabis-Based Dronabinol Could Transform Alzheimer's Care, New Study Finds
An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...
Rolling Out4d
Managing dementia: 7 promising advances in understanding the condition
Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...
Critical Flaws: New Alzheimer’s Drug Could Actually Be a Safety Risk
An investigation has uncovered alarming issues including increased mortality rates, absent safety records, dubious efficacy, ...
verywellhealth9d
7 Alternative Dementia Therapies to Help Relieve Symptoms
Dementia therapies may help relieve symptoms, but many different options are available. Some may help more than others.
earth2d
Synthetic cannabis reduces agitation in Alzheimer’s patients
An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...
The Victoria Advocate13d
A PILL FOR ALZHEIMER'S DISEASE? CLINICAL TRIALS ON A NEW APPROACH TO TREATING ALZHEIMER'S STARTS AT 50 MEDICAL CENTERS ACROSS THE COUNTRY
"The approach of using benfotiamine in patients with mild Alzheimer's is very promising," said Rajiv Ratan, M.D., Ph.D., Executive Director at Burke Neurological Institute. "This clinical trial ...